Matthew E. Monaghan - Net Worth and Insider Trading

Matthew E. Monaghan Net Worth

The estimated net worth of Matthew E. Monaghan is at least $864,222 dollars as of 2024-04-19. Matthew E. Monaghan is the Director of Syneos Health Inc and owns about 19,777 shares of Syneos Health Inc (SYNH) stock worth over $850,015. Matthew E. Monaghan is also the Chairman, President and CEO of Invacare Corp and owns about 1,052,346 shares of Invacare Corp (IVCRQ) stock worth over $14,207. Details can be seen in Matthew E. Monaghan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew E. Monaghan has not made any transactions after 2022-05-31 and currently still holds the listed stock(s).

Transaction Summary of Matthew E. Monaghan

To

Matthew E. Monaghan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew E. Monaghan owns 2 companies in total, including Syneos Health Inc (SYNH) , and Invacare Corp (IVCRQ) .

Click here to see the complete history of Matthew E. Monaghan’s form 4 insider trades.

Insider Ownership Summary of Matthew E. Monaghan

Ticker Comapny Transaction Date Type of Owner
SYNH Syneos Health Inc 2022-05-31 director
IVCRQ Invacare Corp 2022-03-11 President and CEO

Matthew E. Monaghan Latest Holdings Summary

Matthew E. Monaghan currently owns a total of 2 stocks. Among these stocks, Matthew E. Monaghan owns 19,777 shares of Syneos Health Inc (SYNH) as of May 31, 2022, with a value of $850,015 and a weighting of 98.36%. Matthew E. Monaghan also owns 1,052,346 shares of Invacare Corp (IVCRQ) as of March 11, 2022, with a value of $14,207 and a weighting of 1.64%.

Latest Holdings of Matthew E. Monaghan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SYNH Syneos Health Inc 2022-05-31 19,777 42.98 850,015
IVCRQ Invacare Corp 2022-03-11 1,052,346 0.01 14,207

Holding Weightings of Matthew E. Monaghan


Matthew E. Monaghan Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew E. Monaghan has made a total of 2 transactions in Syneos Health Inc (SYNH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Syneos Health Inc is the sale of 200 shares on May 31, 2022, which brought Matthew E. Monaghan around $14,870.

According to the SEC Form 4 filings, Matthew E. Monaghan has made a total of 1 transactions in Invacare Corp (IVCRQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Invacare Corp is the acquisition of 33,000 shares on March 11, 2022, which cost Matthew E. Monaghan around $49,170.

Insider Trading History of Matthew E. Monaghan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew E. Monaghan Trading Performance

GuruFocus tracks the stock performance after each of Matthew E. Monaghan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew E. Monaghan is -3.59%. GuruFocus also compares Matthew E. Monaghan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew E. Monaghan within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew E. Monaghan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew E. Monaghan

Average Return

9.45%

Average return per transaction

Outperforming Transactions

80%

4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.67 -3.59 3.47 9.45 18.46 -9.61
Relative Return to S&P 500(%) -1.59 -5.89 -2.01 -3.49 4.37 -24.12

Matthew E. Monaghan Ownership Network

Ownership Network List of Matthew E. Monaghan

No Data

Ownership Network Relation of Matthew E. Monaghan


Matthew E. Monaghan Owned Company Details

What does Syneos Health Inc do?

Who are the key executives at Syneos Health Inc?

Matthew E. Monaghan is the director of Syneos Health Inc. Other key executives at Syneos Health Inc include Chief Financial Officer Michael J. Bonello , See remarks Stanford Rudnick , and Chief Business Officer Christian Tucat .

Syneos Health Inc (SYNH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Syneos Health Inc (SYNH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Syneos Health Inc (SYNH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Syneos Health Inc (SYNH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syneos Health Inc Insider Transactions

No Available Data

Matthew E. Monaghan Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew E. Monaghan. You might contact Matthew E. Monaghan via mailing address: One Invacare Way, Elyria Oh 44035.

Discussions on Matthew E. Monaghan

No discussions yet.